Reimbursement
The group is pressing CMS to make 2018 another transition year, more cybersecurity incentives and to streamline multiple Meaningful Use programs.
Affordable Care Act's fate is coming into question as healthcare organizations move into the new world of value-based care and other advances.
Canadian drugmaker Valeant Pharmaceuticals International Inc. acquired the medication in February 2015 and abruptly doubled the $1,500 retail price.
Almost 70 percent cited cash flow and reimbursement as their top concerns, with similar numbers saying waiting for payment is painful.
The new model was unveiled in March to test whether alternative payments would have given incentives to prescribe less costly drugs. CMS withdrew the proposal after a CMMI review.
Agency predicts the new opportunities will mean 25 percent of clinicians in QPP will be a part of the APMs.
Because of the last-minute rush, Covered California officials have extended the enrollment deadline for coverage that begins Jan. 1.
State-based effort is an Innovation Center initiative for clinicians to participate in advanced alternative payment models under MACRA.
Health insurance costs equaled 7.6 percent of total compensation for private employers in September.
Measures posted on websites give key quality metrics such as pressure ulcers, readmissions for over 1,100 inpatient rehabilitation facilities.